Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao-Cheng Lin

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Pharmacogenetics and Genomics|February 24, 2006
Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophreniaYing-Jay Liou, I-Ching Lai, Ming-Wei Lin, et al.
Neuropsychobiology|May 1, 2004
Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patientsYing-Jay Liou, Ying-Chieh Wang, Ya-Mei Bai, et al.
Computer Methods and Programs in Biomedicine|May 30, 2008
Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical dataChao-Cheng Lin, Ying-Chieh Wang, Jen-Yeu Chen, et al.
BMC Psychiatry|April 12, 2007
Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptomsChao-Cheng Lin, Ya-Mei Bai, Chia-Yih Liu, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|August 24, 2010
Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophreniaI-Ching Lai, Mao-Liang Chen, Ying-Chieh Wang, et al.
Neuromolecular Medicine|January 1, 2005
Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patientsYing-Jay Liou, Ding-Lieh Liao, Jen-Yeu Chen, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychoticsChao-Cheng Lin, Ya-Mei Bai, Ying-Chieh Wang, et al.
Schizophrenia Research|May 5, 2009
Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort studyYa Mei Bai, Tzu Ting Chen, Wei-Shiung Yang, et al.
The Journal of Clinical Psychiatry|December 29, 2007
Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophreniaYa Mei Bai, Jen-Yeu Chen, Wei-Shiung Yang, et al.
European Journal of Clinical Pharmacology|December 25, 2010
Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophreniaI-Ching Lai, Geng-Han Mo, Mao-Liang Chen, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Pharmacogenetics and Genomics|February 24, 2006
Haplotype analysis of endothelial nitric oxide synthase (NOS3) genetic variants and tardive dyskinesia in patients with schizophreniaYing-Jay Liou, I-Ching Lai, Ming-Wei Lin, et al.
Neuropsychobiology|May 1, 2004
Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patientsYing-Jay Liou, Ying-Chieh Wang, Ya-Mei Bai, et al.
Computer Methods and Programs in Biomedicine|May 30, 2008
Artificial neural network prediction of clozapine response with combined pharmacogenetic and clinical dataChao-Cheng Lin, Ying-Chieh Wang, Jen-Yeu Chen, et al.
BMC Psychiatry|April 12, 2007
Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptomsChao-Cheng Lin, Ya-Mei Bai, Chia-Yih Liu, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|August 24, 2010
Analysis of genetic variations in the human melatonin receptor (MTNR1A, MTNR1B) genes and antipsychotics-induced tardive dyskinesia in schizophreniaI-Ching Lai, Mao-Liang Chen, Ying-Chieh Wang, et al.
Neuromolecular Medicine|January 1, 2005
Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patientsYing-Jay Liou, Ding-Lieh Liao, Jen-Yeu Chen, et al.
Journal of Clinical Psychopharmacology|November 14, 2009
Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychoticsChao-Cheng Lin, Ya-Mei Bai, Ying-Chieh Wang, et al.
Schizophrenia Research|May 5, 2009
Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort studyYa Mei Bai, Tzu Ting Chen, Wei-Shiung Yang, et al.
The Journal of Clinical Psychiatry|December 29, 2007
Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophreniaYa Mei Bai, Jen-Yeu Chen, Wei-Shiung Yang, et al.
European Journal of Clinical Pharmacology|December 25, 2010
Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophreniaI-Ching Lai, Geng-Han Mo, Mao-Liang Chen, et al.
Pageof 6